| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.03 |